Features of use of angiotensin receptor blockers in clinical practice (focus on candesartan)


A.G. Evdokimova, Е.V. Коvаlеnко, V.V. Evdokimov, К.I. Теblоеv, I.А. Shvetsova

A.I. Yevdokimov Moscow state university of medicine and dentistry, Моscow
Modern treatment of cardiovascular diseases includes the administration of angiotensin II receptor blockers. This article provides an overview of published data on the efficacy, safety, and high adherence to the treatment with candesartan in patients with arterial hypertension, diabetes mellitus, chronic heart failure, and chronic kidney disease. The benefits of candesartan in comparison with other members of this group of drugs are emphasized.
Keywords: candesartan, chronic heart failure, arterial hypertension, chronic kidney disease
Read entire article

About the Autors

Anna G. Yevdokimova, MD, professor of the Department of hospital therapy № 2, A.I. Yevdokimov Moscow state university of medicine and dentistry. Address: 127473, Moscow. 20/1 Delegatskaya St. Tel.: +74991929775. E-mail: aevdokimova@rambler.ru

Vladimir V. Yevdokimov, PhD, associate professor of the Department of hospital therapy № 2, A.I. Yevdokimov Moscow state university of medicine and dentistry. Address: 127473, Moscow. 20/1 Delegatskaya St. Tel.: +74991929775

Yelena V. Kovalenko, PhD, associate professor of the Department of hospital therapy № 2, A.I. Yevdokimov Moscow state university of medicine and dentistry. Address: 127473, Moscow. 20/1 Delegatskaya St. Tel.: +74991929775

Konstantin I. Tebloev, MD, professor, head of the Department of hospital therapy № 2, A.I. Yevdokimov Moscow state university of medicine and dentistry. Address: 127473, Moscow. 20/1 Delegatskaya St. Tel.: +74991929775

Inna A. Shvetcova, Department of hospital therapy № 2, A.I. Yevdokimov Moscow state university of medicine and dentistry. Address: 127473, Moscow. 20/1 Delegatskaya St. Tel.: +74991929775


Similar Articles

Back to Content

Бионика Медиа